Search Results

There are 6584 results for: content related to: Combination therapy with sulfonylureas and metformin and the prevention of death in type 2 diabetes: a nested case-control study

  1. Sulfonylureas: Basic Aspects and Clinical Uses

    Standard Article

    International Textbook of Diabetes Mellitus

    H.E. Lebovitz and A. Melander

    Published Online : 15 MAR 2004, DOI: 10.1002/0470862092.d0608

  2. Cardiovascular safety of sulfonylureas: a meta-analysis of randomized clinical trials

    Diabetes, Obesity and Metabolism

    Volume 15, Issue 10, October 2013, Pages: 938–953, M. Monami, S. Genovese and E. Mannucci

    Article first published online : 13 MAY 2013, DOI: 10.1111/dom.12116

  3. Can people with type 2 diabetes live longer than people without diabetes? A comparison of all-cause mortality in people initiated with metformin monotherapy or sulfonylurea monotherapy and matched controls without diabetes.

    Diabetes, Obesity and Metabolism

    Accepted manuscript online: 7 JUL 2014, Christian A. Bannister, Sarah E. Holden, Sara Jenkins-Jones, Christopher Ll. Morgan, Julian P. Halcox, Guntram Schernthaner, Jayanti Mukherjee and Craig J. Currie

    DOI: 10.1111/dom.12354

  4. Combination Therapy in Type 2 Diabetes

    Standard Article

    International Textbook of Diabetes Mellitus

    Mandeep Bajaj and Ralph A. DeFronzo

    Published Online : 15 APR 2004, DOI: 10.1002/0470862092.d0613

  5. Combine and conquer: advantages and disadvantages of fixed-dose combination therapy

    Diabetes, Obesity and Metabolism

    Volume 15, Issue 4, April 2013, Pages: 291–300, D. S. H. Bell

    Article first published online : 25 OCT 2012, DOI: 10.1111/dom.12015

  6. The risk of overall mortality in patients with Type 2 diabetes receiving different combinations of sulfonylureas and metformin: a retrospective analysis

    Diabetic Medicine

    Volume 29, Issue 8, August 2012, Pages: 1029–1035, K. M. Pantalone, M. W. Kattan, C. Yu, B. J. Wells, S. Arrigain, B. Nutter, A. Jain, A. Atreja and R. S. Zimmerman

    Article first published online : 15 JUL 2012, DOI: 10.1111/j.1464-5491.2012.03577.x

  7. Assessment of effects on non-target plants from sulfonylurea herbicides using field approaches

    Pesticide Science

    Volume 52, Issue 3, March 1998, Pages: 199–217, Timothy T. Obrigawitch, Gilbert Cook and Jeff Wetherington

    Article first published online : 26 MAR 1999, DOI: 10.1002/(SICI)1096-9063(199803)52:3<199::AID-PS696>3.0.CO;2-Y

  8. Combination Use of Sulfonylureas and Insulin in the Treatment of Noninsulin-Dependent Diabetes Mellitus

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 12, Issue 4, July-August 1992, Pages: 292–299, Patricia A. Montgomery

    Article first published online : 24 FEB 2012, DOI: 10.1002/j.1875-9114.1992.tb04463.x

  9. Effect of antidiabetic agents added to metformin on glycaemic control, hypoglycaemia and weight change in patients with type 2 diabetes: a network meta-analysis

    Diabetes, Obesity and Metabolism

    Volume 14, Issue 9, September 2012, Pages: 810–820, S.-C. Liu, Y.-K. Tu, M.-N. Chien and K.-L. Chien

    Article first published online : 29 APR 2012, DOI: 10.1111/j.1463-1326.2012.01606.x

  10. You have full text access to this OnlineOpen article
    The risk of heart failure in patients with type 2 diabetes treated with oral agent monotherapy

    European Journal of Heart Failure

    Volume 10, Issue 7, July 2008, Pages: 703–708, Finlay A. McAlister, Dean T. Eurich, Sumit R. Majumdar and Jeffrey A. Johnson

    Article first published online : 13 JAN 2014, DOI: 10.1016/j.ejheart.2008.05.013

  11. Nonadherence as a predictor of antidiabetic drug therapy intensification (augmentation)

    Pharmacoepidemiology and Drug Safety

    Volume 13, Issue 9, September 2004, Pages: 591–598, Dr Stephen J. Kogut, Susan E. Andrade, Cynthia Willey and E. Paul Larrat

    Article first published online : 17 AUG 2004, DOI: 10.1002/pds.1005

  12. Variations in tissue selectivity amongst insulin secretagogues: a systematic review

    Diabetes, Obesity and Metabolism

    Volume 14, Issue 2, February 2012, Pages: 130–138, A. S. Abdelmoneim, S. E. Hasenbank, J. M. Seubert, D. R. Brocks, P. E. Light and S. H. Simpson

    Article first published online : 2 NOV 2011, DOI: 10.1111/j.1463-1326.2011.01496.x

  13. Mortality risk with sulphonylureas compared to metformin

    Diabetes, Obesity and Metabolism

    S. E. Holden and C. J. Currie

    Article first published online : 14 MAR 2014, DOI: 10.1111/dom.12280

  14. All-cause mortality in diabetic patients treated with combinations of sulfonylureas and biguanides

    Diabetes/Metabolism Research and Reviews

    Volume 20, Issue 1, January/February 2004, Pages: 44–47, Edoardo Mannucci, Matteo Monami, Giulio Masotti and Niccolò Marchionni

    Article first published online : 27 OCT 2003, DOI: 10.1002/dmrr.411

  15. Metformin and Other Biguanides: Pharmacology and Therapeutic Usage

    Standard Article

    International Textbook of Diabetes Mellitus

    Alan J. Garber

    Published Online : 15 MAR 2004, DOI: 10.1002/0470862092.d0610

  16. Glyburide: A Second-generation Sulfonylurea Hypoglycemic Agent

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 5, Issue 2, March-April 1985, Pages: 43–62, Jerome M. Feldman

    Article first published online : 24 JAN 2012, DOI: 10.1002/j.1875-9114.1985.tb03404.x

  17. Evidence for more than One Binding Site for Sulfonylureas in Insulin-secreting Cells

    Journal of Pharmacy and Pharmacology

    Volume 42, Issue 4, April 1990, Pages: 230–235, E. J. Verspohl, H. P. T. Ammon and M. Mark

    Article first published online : 12 APR 2011, DOI: 10.1111/j.2042-7158.1990.tb05398.x

  18. Sulfonylurea Treatment of Type 2 Diabetes Mellitus: Focus on Glimepiride

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 24, Issue 5, May 2004, Pages: 606–620, Mary T. Korytkowski

    Article first published online : 16 JAN 2012, DOI: 10.1592/phco.24.6.606.34752

  19. Secondary Failure Rates Associated with Metformin and Sulfonylurea Therapy for Type 2 Diabetes Mellitus

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 25, Issue 6, June 2005, Pages: 810–816, Mr. Dean T. Eurich, Dr. Scot H. Simpson, Dr. Sumit R. Majumdar and Dr. Jeffrey A. Johnson

    Article first published online : 16 JAN 2012, DOI: 10.1592/phco.2005.25.6.810

  20. Coronary heart disease outcomes in patients receiving antidiabetic agents

    Pharmacoepidemiology and Drug Safety

    Volume 16, Issue 7, July 2007, Pages: 711–725, Andrew T. McAfee, Carol Koro, Joan Landon, Najat Ziyadeh and Alexander M. Walker

    Article first published online : 6 JUN 2007, DOI: 10.1002/pds.1443